Oncotarget

Research Papers:

Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma

Tao Pang, Xinghua Wang, Jun Gao, Wei Chen, Xiao Jun Shen, Ming Ming Nie, Tianhang Luo, Kai Yin, Guoen Fang, Kai Xuan Wang and Xu Chao Xue _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:76468-76478. https://doi.org/10.18632/oncotarget.20273

Metrics: PDF 1545 views  |   HTML 2116 views  |   ?  


Abstract

Tao Pang1,*, Xinghua Wang2,*, Jun Gao3, Wei Chen4, Xiao Jun Shen1, Ming Ming Nie1, Tianhang Luo1, Kai Yin1, Guoen Fang1, Kai Xuan Wang3 and Xu Chao Xue1

1Department of Gastrointestinal Surgery, ChangHai Hospital, Second Military Medical University, ShangHai, China

2Department of Microbiology, Second Military Medical University, ShangHai, China

3Department of Gastroenterology, ChangHai Hospital, Second Military Medical University, ShangHai, China

4Department of Cardiology, ChangZheng Hospital, Second Military Medical University, ShangHai, China

*Co-authors

Correspondence to:

Xu Chao Xue, email: [email protected]

Keywords: recombinant oncolytic adenovirus, cancer associated fibroblasts, fibroblast activation protein, stromal-derived factor 1, gastric carcinoma

Received: November 10, 2016     Accepted: July 11, 2017     Published: August 16, 2017

ABSTRACT

Objective: To evaluate the effects of fiber-modified hexon-chimeric recombinant oncolytic adenovirus targeting cancer associated fibroblasts (CAFs) on the gastric CAFs and the transplantation tumor mice model of gastric carcinoma (GC).

Results: Compared with BJ cells and GPFs, the reproduction and infectivity of P9, P9-4C or GP adenoviruses were markedly higher in gastric CAFs. In addition, P9, P9-4C or GP had a significantly relatively more killing effect on gastric CAFs compared with GPFs, and have less oncolytic effect in BJ cells. Furthermore, in transplantation tumor mice model of GC we found significantly higher hexon protein expression in tumor tissues, more decreasing tumor growth and increasing inhibitory rates after treatment of P9, P9-4C or GP adenoviruses compared with Ad adenovirus.

Materials and Methods: Based on the construction of the recombinant oncolytic adenoviruses pRCAdHVR48-SDF1p-Ad/EGFP (Ad, as control) with the E1A gene transcription regulated by stromal-derived factor 1 (SDF1) promoter and the hexon replaced by hexon-chimeric (H5HVR48) gene, three fiber-modified hexon-chimeric oncolytic adenovirus through the modification fiber protein by insertion of different short peptides specifically binding to fibroblast activation protein (FAP), including pRCAdHVR48-SDF1p-FAP-P9/EGFP (P9), pRCAdHVR48-SDF1p-FAP-P9-4C/EGFP (P9-4C), pRCAdHVR48-SDF1p-FAP-GP/EGFP (GP), and their corresponding replication-defective adenovirus in parallel were reconstructed. Then the reproduction, infectivity and killing ability of the four above recombinant adenoviruses were evaluated in gastric CAFs compared with gastric para-mucosa fibroblasts (GPFs) and neonatal human foreskin fibroblasts (BJ). Furthermore, transplantation tumor mice model of GC was established, and then treated by the four above recombinant adenoviruses. Tumor size and tumor growth inhibitory rates were calculated, and histomorphology by HE staining and hexon expressions by immunohistochemistry were evaluated in tumor tissues.

Conclusions: The fiber-modified hexon-chimeric recombinant oncolytic adenovirus targeting CAFs can relatively specifically kill gastric CAFs and inhibit GC cells growth in vivo.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20273